Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Drug-related mortality after discharge from treatment: A record-linkage study of substance abuse clients in Texas, 2006-2012.

Maughan BC, Becker EA.

Drug Alcohol Depend. 2019 Aug 30;204:107473. doi: 10.1016/j.drugalcdep.2019.05.011. [Epub ahead of print]

PMID:
31520924
2.

A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma.

Hahn AW, Drake C, Denmeade SR, Zakharia Y, Maughan BL, Kennedy E, Link C Jr, Vahanian N, Hammers H, Agarwal N.

Oncologist. 2019 Sep 6. pii: theoncologist.2019-0599. doi: 10.1634/theoncologist.2019-0599. [Epub ahead of print]

PMID:
31492769
3.

Patterns of treatment in metastatic renal cell carcinoma for older versus younger patients.

Hahn AW, Esther J, Haaland B, Swami U, Dizman N, Rathi N, Maughan BL, Pal SK, Agarwal N.

J Geriatr Oncol. 2019 Aug 8. pii: S1879-4068(19)30128-6. doi: 10.1016/j.jgo.2019.07.002. [Epub ahead of print] No abstract available.

PMID:
31402176
4.

Bundled Payments For Hospitals: The Authors Reply.

Maughan BC, Marrufo G, Kahvecioglu DC.

Health Aff (Millwood). 2019 Jul;38(7):1230. doi: 10.1377/hlthaff.2019.00613. No abstract available.

PMID:
31260356
5.

Adoptees' responses to separation from, and reunion with, their adoptive parent at age 4 years is associated with long-term persistence of autism symptoms following early severe institutional deprivation.

Sonuga-Barke E, Kennedy M, Golm D, Knights N, Kovshoff H, Kreppner J, Kumsta R, Maughan B, O'Connor TG, Schlotz W.

Dev Psychopathol. 2019 Jun 13:1-10. doi: 10.1017/S0954579419000506. [Epub ahead of print]

PMID:
31190672
6.

Cross-cohort change in adolescent outcomes for children with mental health problems.

Sellers R, Warne N, Pickles A, Maughan B, Thapar A, Collishaw S.

J Child Psychol Psychiatry. 2019 Jul;60(7):813-821. doi: 10.1111/jcpp.13029. Epub 2019 Apr 15.

7.

Medicare's Bundled Payments For Care Improvement Initiative Maintained Quality Of Care For Vulnerable Patients.

Maughan BC, Kahvecioglu DC, Marrufo G, Gerding GM, Dennen S, Marshall JK, Cooper DM, Kummet CM, Dummit LA.

Health Aff (Millwood). 2019 Apr;38(4):561-568. doi: 10.1377/hlthaff.2018.05146.

PMID:
30933596
8.

No man is an island: social resources, stress and mental health at mid-life.

Sehmi R, Maughan B, Matthews T, Arseneault L.

Br J Psychiatry. 2019 Mar 4:1-7. doi: 10.1192/bjp.2019.25. [Epub ahead of print]

PMID:
30827291
9.

Mechanisms underlying social gradients in child and adolescent antisocial behaviour.

Piotrowska PJ, Stride CB, Maughan B, Rowe R.

SSM Popul Health. 2019 Jan 14;7:100353. doi: 10.1016/j.ssmph.2019.100353. eCollection 2019 Apr.

10.

Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors.

Esther J, Hale P, Hahn AW, Agarwal N, Maughan BL.

Drugs Aging. 2019 May;36(5):395-401. doi: 10.1007/s40266-019-00644-1.

PMID:
30784023
11.

Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.

Hahn AW, Stenehjem D, Nussenzveig R, Carroll E, Bailey E, Batten J, Maughan BL, Agarwal N.

Cancer Treat Res Commun. 2019;19:100120. doi: 10.1016/j.ctarc.2019.100120. Epub 2019 Feb 6.

PMID:
30743187
12.

Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction.

Esther J, Maughan BL, Anderson N, Agarwal N, Hahn AW.

Curr Treat Options Oncol. 2019 Feb 11;20(2):14. doi: 10.1007/s11864-019-0611-z. Review.

PMID:
30741354
13.

Randomized phase II trial of sipuleucel-T immunotherapy preceded by sensitizing radiation therapy and sipuleucel-T alone in patients with metastatic castrate resistant prostate cancer.

Twardowski P, Wong JYC, Pal SK, Maughan BL, Frankel PH, Franklin K, Junqueira M, Prajapati MR, Nachaegari G, Harwood D, Agarwal N.

Cancer Treat Res Commun. 2019;19:100116. doi: 10.1016/j.ctarc.2018.100116. Epub 2018 Dec 20.

PMID:
30682445
14.

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma.

Stenehjem DD, Hahn AW, Gill DM, Albertson D, Gowrishankar B, Merriman J, Agarwal AM, Thodima V, Harrington EB, Au TH, Maughan BL, Houldsworth J, Pal SK, Agarwal N.

PLoS One. 2019 Jan 25;14(1):e0210415. doi: 10.1371/journal.pone.0210415. eCollection 2019.

15.

Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC).

Hahn AW, Gill DM, Poole A, Nussenzveig RH, Wilson S, Farnham JM, Stephenson RA, Cannon-Albright LA, Maughan BL, Agarwal N.

Mol Cancer Ther. 2019 Mar;18(3):726-729. doi: 10.1158/1535-7163.MCT-18-0739. Epub 2018 Dec 26.

PMID:
30587554
16.

Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.

Maughan BL, Pal SK, Gill D, Boucher K, Martin C, Salgia M, Nussenzveig R, Liu T, Hawks JL, Batten J, Nachaegari G, Stephenson R, Lowrance W, Jones J, Dechet C, Agarwal N.

Oncologist. 2018 Dec;23(12):1413-e151. doi: 10.1634/theoncologist.2018-0652. Epub 2018 Nov 1.

17.

Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities.

Sirohi D, Smith SC, Agarwal N, Maughan BL.

Res Rep Urol. 2018 Nov 15;10:205-217. doi: 10.2147/RRU.S154932. eCollection 2018. Review.

18.

Are punitive parenting and stressful life events environmental risk factors for obsessive-compulsive symptoms in youth? A longitudinal twin study.

Krebs GC, Hannigan LJ, Gregory AM, Rijsdijk FV, Maughan B, Eley TC.

Eur Psychiatry. 2019 Feb;56:35-42. doi: 10.1016/j.eurpsy.2018.11.004. Epub 2018 Nov 26.

19.

Developmental Contributions of Schizophrenia Risk Alleles and Childhood Peer Victimization to Early-Onset Mental Health Trajectories.

Riglin L, Hammerton G, Heron J, Collishaw S, Arseneault L, Thapar AK, Maughan B, O'Donovan MC, Thapar A.

Am J Psychiatry. 2019 Jan 1;176(1):36-43. doi: 10.1176/appi.ajp.2018.18010075. Epub 2018 Nov 29.

20.

The Earlier the Better? Pausing for Thought ….

Maughan B, Barker ED.

Child Dev. 2019 Jan;90(1):20-24. doi: 10.1111/cdev.13168. Epub 2018 Oct 20.

PMID:
30341949
21.

Childhood maltreatment and adult medical morbidity in mood disorders: comparison of unipolar depression with bipolar disorder.

Hosang GM, Fisher HL, Hodgson K, Maughan B, Farmer AE.

Br J Psychiatry. 2018 Nov;213(5):645-653. doi: 10.1192/bjp.2018.178. Epub 2018 Sep 20.

22.

A Broader View of Quality: Choosing Wisely Recommendations From Other Specialties With High Relevance to Emergency Care.

Maughan BC, Rabin E, Cantrill SV; ACEP Quality and Patient Safety Committee Workgroup on Choosing Wisely.

Ann Emerg Med. 2018 Sep;72(3):246-253. doi: 10.1016/j.annemergmed.2018.06.041.

PMID:
30144861
23.

Geographic variation in postpartum prescription opioid use: Opportunities to improve maternal safety.

Becker NV, Gibbins KJ, Perrone J, Maughan BC.

Drug Alcohol Depend. 2018 Jul 1;188:288-294. doi: 10.1016/j.drugalcdep.2018.04.011. Epub 2018 May 12.

PMID:
29807216
24.

Long term economic impact associated with childhood bullying victimisation.

Brimblecombe N, Evans-Lacko S, Knapp M, King D, Takizawa R, Maughan B, Arseneault L.

Soc Sci Med. 2018 Jul;208:134-141. doi: 10.1016/j.socscimed.2018.05.014. Epub 2018 May 8.

PMID:
29803971
25.

Better governance, better access: practising responsible data sharing in the METADAC governance infrastructure.

Murtagh MJ, Blell MT, Butters OW, Cowley L, Dove ES, Goodman A, Griggs RL, Hall A, Hallowell N, Kumari M, Mangino M, Maughan B, Mills MC, Minion JT, Murphy T, Prior G, Suderman M, Ring SM, Rogers NT, Roberts SJ, Van der Straeten C, Viney W, Wiltshire D, Wong A, Walker N, Burton PR.

Hum Genomics. 2018 Apr 26;12(1):24. doi: 10.1186/s40246-018-0154-6.

26.

Investigating late-onset ADHD: a population cohort investigation.

Cooper M, Hammerton G, Collishaw S, Langley K, Thapar A, Dalsgaard S, Stergiakouli E, Tilling K, Davey Smith G, Maughan B, O'Donovan M, Thapar A, Riglin L.

J Child Psychol Psychiatry. 2018 Oct;59(10):1105-1113. doi: 10.1111/jcpp.12911. Epub 2018 Apr 23.

27.

Resilience in high-risk adolescents of mothers with recurrent depressive disorder: The contribution of fathers.

Mahedy L, Harold GT, Maughan B, Gardner F, Araya R, Bevan Jones R, Hammerton G, Sellers R, Thapar A, Collishaw S.

J Adolesc. 2018 Jun;65:207-218. doi: 10.1016/j.adolescence.2018.03.016. Epub 2018 Apr 7.

28.

Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs.

Bachhuber MA, Saloner B, LaRochelle M, Merlin JS, Maughan BC, Polsky D, Shaparin N, Murphy SM.

Pain Med. 2018 Oct 1;19(10):1952-1960. doi: 10.1093/pm/pny053.

PMID:
29618105
29.

Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma.

Gill DM, Hahn AW, Hale P, Maughan BL.

Curr Treat Options Oncol. 2018 Jan 24;19(1):6. doi: 10.1007/s11864-018-0517-1. Review.

PMID:
29368125
30.

Low resting heart rate, sensation seeking and the course of antisocial behaviour across adolescence and young adulthood.

Hammerton G, Heron J, Mahedy L, Maughan B, Hickman M, Murray J.

Psychol Med. 2018 Oct;48(13):2194-2201. doi: 10.1017/S0033291717003683. Epub 2018 Jan 9.

31.

Multisystemic therapy not superior to management as usual for adolescent antisocial behaviour in an English trial.

Maughan B, Gardner F.

Lancet Psychiatry. 2018 Feb;5(2):94-95. doi: 10.1016/S2215-0366(18)30002-6. Epub 2018 Jan 5. No abstract available.

PMID:
29307526
32.

p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer.

Maughan BL, Guedes LB, Boucher K, Rajoria G, Liu Z, Klimek S, Zoino R, Antonarakis ES, Lotan TL.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):260-268. doi: 10.1038/s41391-017-0027-4. Epub 2018 Jan 4.

PMID:
29302046
33.

The impact of schizophrenia and mood disorder risk alleles on emotional problems: investigating change from childhood to middle age.

Riglin L, Collishaw S, Richards A, Thapar AK, Rice F, Maughan B, O'Donovan MC, Thapar A.

Psychol Med. 2018 Oct;48(13):2153-2158. doi: 10.1017/S0033291717003634. Epub 2017 Dec 14.

PMID:
29239291
34.

Comparing the characteristics and outcomes of parent- and teacher-reported oppositional defiant disorder: findings from a national sample.

McNeilis J, Maughan B, Goodman R, Rowe R.

J Child Psychol Psychiatry. 2018 Jun;59(6):659-666. doi: 10.1111/jcpp.12845. Epub 2017 Dec 12.

35.

HPA axis dysregulation in adult adoptees twenty years after severe institutional deprivation in childhood.

Kumsta R, Schlotz W, Golm D, Moser D, Kennedy M, Knights N, Kreppner J, Maughan B, Rutter M, Sonuga-Barke E.

Psychoneuroendocrinology. 2017 Dec;86:196-202. doi: 10.1016/j.psyneuen.2017.09.021. Epub 2017 Sep 28.

36.

Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer.

Poole A, Gill D, Hahn AW, Johnson E, Carroll E, Boucher K, Nussenzveig R, Maughan B, Agarwal N.

Clin Genitourin Cancer. 2017 Sep 6. pii: S1558-7673(17)30272-0. doi: 10.1016/j.clgc.2017.08.017. [Epub ahead of print]

PMID:
28958675
37.

Investigating the genetic underpinnings of early-life irritability.

Riglin L, Eyre O, Cooper M, Collishaw S, Martin J, Langley K, Leibenluft E, Stringaris A, Thapar AK, Maughan B, O'Donovan MC, Thapar A.

Transl Psychiatry. 2017 Sep 26;7(9):e1241. doi: 10.1038/tp.2017.212.

38.

Effects of Excessive Alcohol Use on Antisocial Behavior Across Adolescence and Early Adulthood.

Hammerton G, Mahedy L, Murray J, Maughan B, Edwards AC, Kendler KS, Hickman M, Heron J.

J Am Acad Child Adolesc Psychiatry. 2017 Oct;56(10):857-865. doi: 10.1016/j.jaac.2017.07.781. Epub 2017 Aug 3.

39.

Adult disinhibited social engagement in adoptees exposed to extreme institutional deprivation: examination of its clinical status and functional impact.

Kennedy M, Kreppner J, Knights N, Kumsta R, Maughan B, Golm D, Hill J, Rutter M, Schlotz W, Sonuga-Barke E.

Br J Psychiatry. 2017 Nov;211(5):289-295. doi: 10.1192/bjp.bp.117.200618. Epub 2017 Sep 21.

40.

A Methylome-Wide Association Study of Trajectories of Oppositional Defiant Behaviors and Biological Overlap With Attention Deficit Hyperactivity Disorder.

Barker ED, Walton E, Cecil CAM, Rowe R, Jaffee SR, Maughan B, O'Connor TG, Stringaris A, Meehan AJ, McArdle W, Relton CL, Gaunt TR.

Child Dev. 2018 Sep;89(5):1839-1855. doi: 10.1111/cdev.12957. Epub 2017 Sep 20.

41.

PD-1 checkpoint inhibition: Toxicities and management.

Hahn AW, Gill DM, Agarwal N, Maughan BL.

Urol Oncol. 2017 Dec;35(12):701-707. doi: 10.1016/j.urolonc.2017.08.005. Epub 2017 Sep 8.

PMID:
28889921
42.

Childhood maltreatment and the medical morbidity in bipolar disorder: a case-control study.

Hosang GM, Fisher HL, Uher R, Cohen-Woods S, Maughan B, McGuffin P, Farmer AE.

Int J Bipolar Disord. 2017 Sep 7;5(1):30. doi: 10.1186/s40345-017-0099-z.

43.

The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer.

Harshman LC, Werner L, Tripathi A, Wang X, Maughan BL, Antonarakis ES, Nakabayashi M, McKay R, Pomerantz M, Mucci LA, Taplin ME, Sweeney CJ, Lee GM, Kantoff PW.

Prostate. 2017 May;77(13):1303-1311. doi: 10.1002/pros.23390. Epub 2017 Aug 1.

44.

Neonatal DNA methylation and early-onset conduct problems: A genome-wide, prospective study.

Cecil CAM, Walton E, Jaffee SR, O'Connor T, Maughan B, Relton CL, Smith RG, McArdle W, Gaunt TR, Ouellet-Morin I, Barker ED.

Dev Psychopathol. 2018 May;30(2):383-397. doi: 10.1017/S095457941700092X. Epub 2017 Jun 9.

PMID:
28595673
45.

Externalizing Behaviors and Callous-Unemotional Traits: Different Associations With Sleep Quality.

Denis D, Akhtar R, Holding BC, Murray C, Panatti J, Claridge G, Sadeh A, Barclay NL, O'Leary R, Maughan B, McAdams TA, Rowe R, Eley TC, Viding E, Gregory AM.

Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx070.

46.

Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration.

Terada N, Maughan BL, Akamatsu S, Kobayashi T, Yamasaki T, Inoue T, Kamba T, Ogawa O, Antonarakis ES.

Int J Urol. 2017 Jun;24(6):441-448. doi: 10.1111/iju.13346. Epub 2017 Apr 28.

47.

A More Common Massive Retroperitoneal Mass.

O'Neil B, Maughan B.

JAMA Surg. 2017 Aug 1;152(8):802-803. doi: 10.1001/jamasurg.2017.0546. No abstract available.

PMID:
28445575
48.

Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors.

Bailey EB, Merriman J, Maughan B, Poole A, Tantravahi SK, Agarwal AM, Batten JA, Patel SB, Pal SK, Stenehjem DD, Agarwal N.

J Oncol Pharm Pract. 2018 Apr;24(3):190-197. doi: 10.1177/1078155217693426. Epub 2017 Feb 20.

PMID:
28436250
49.

Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications.

Hahn AW, Gill DM, Maughan B, Agarwal A, Arjyal L, Gupta S, Streeter J, Bailey E, Pal SK, Agarwal N.

Oncotarget. 2017 May 16;8(20):33614-33620. doi: 10.18632/oncotarget.16833.

50.

Incidence of Immune-Related Adverse Events with Program Death Receptor-1- and Program Death Receptor-1 Ligand-Directed Therapies in Genitourinary Cancers.

Maughan BL, Bailey E, Gill DM, Agarwal N.

Front Oncol. 2017 Apr 3;7:56. doi: 10.3389/fonc.2017.00056. eCollection 2017. Review.

Supplemental Content

Loading ...
Support Center